Morgan Lewis Advises Oaktree on $150 Million Debt Refinancing for Aquestive Therapeutics
May 14, 2026NEW YORK, May 14, 2026: Morgan Lewis advised funds managed by Oaktree Capital Management in connection with Aquestive Therapeutics Inc.’s new $150 million debt facility, the proceeds of which will be used to refinance Aquestive’s existing debt facility and for working capital and general corporate purposes.
Oaktree is a global investment manager specializing in alternative investments, with $223 billion in assets under management as of December 31, 2025. Aquestive is a pharmaceutical company advancing medicines to bring improvement to patients' lives through innovative science and delivery technologies.
Morgan Lewis partners Kate Weinstein, Jon English, Jennifer Feldsher, Greer Longer, Chuck Bogle, Leland Benton, Maarika Kimbrell, and Randy McGeorge, and associates Emily Pollak and David Bionghi advised Oaktree.